在阿尔茨海默氏症和艾滋病毒相关的神经认知障碍中,微质功能障碍和胺β病理学
George Chigozie Njoku1,2, Georgette Djuidje Kanmogne1
1Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-4455, USA.
International journal of molecular sciences
|September 27, 2025
概括
微质功能障碍驱动神经炎症,并在阿尔茨海默病 (AD) 和艾滋病毒相关的神经认知障碍 (HAND) 中损害蛋白质清除. 艾滋病毒蛋白质破坏微质受体,恶化神经毒性和粉样蛋白积累.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 慢性神经炎症和蛋白质清除受损是神经退行性疾病的特征,如阿尔茨海默病 (AD) 和艾滋病毒相关的神经认知障碍 (HAND).
- 微质细胞,大脑的免疫细胞,通过清除像粉样β (Aβ) 这样的错误折叠蛋白质,对维持平衡至关重要.
- 在AD和HAND中微质功能障碍加剧了炎症,阻碍了Aβ清除,并导致神经元损伤.
研究的目的:
- 审查微质模式识别受体如何协调Aβ感知,吸收和炎症反应.
- 阐明HIV感染和病毒蛋白质破坏这些微质通路的机制.
- 确定了解艾滋病毒对微质功能的影响及其对HAND的影响的差距.
主要方法:
- 综合来自人类和动物研究的证据.
- 在Aβ处理中分析TREM2,TLR和拾尸体受体在Aβ处理中的作用.
- 检查HIV蛋白 (Tat,gp120) 对微质受体表达,溶酶体功能和新陈代谢的影响.
主要成果:
- 关键的微质受体 (TREM2,TLR,SR) 是Aβ感知,吸收和炎症信号的核心.
- 艾滋病毒感染和病毒蛋白质通过改变受体表达和微质功能来破坏这些途径.
- 这种干扰会产生神经毒性和粉样蛋白积累的循环.
结论:
- 微质功能障碍和受体信号干扰在AD和HAND病变发生过程中至关重要.
- 艾滋病毒积极损害了对大脑平衡至关重要的微质功能.
- 需要进一步的研究,以充分了解艾滋病毒对微质细胞的影响,并开发针对手的向疗法.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K


